Evidence map›Paper›PMID 35403545›Full record

ArticleAutophagy2023

Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis.

Xin Chen, Xinxin Song, Jingbo Li, Ruoxi Zhang, Chunhua Yu, Zhuan Zhou, Jiao Liu, Siyan Liao, Daniel J Klionsky, Guido Kroemer and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Xin ChenDAMP Lab, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID 0000-0003-3668-4830
Xinxin SongDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
Jingbo LiDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
Ruoxi ZhangDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-2538-1877
Chunhua YuDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
Zhuan ZhouDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
Jiao LiuDAMP Lab, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Siyan LiaoGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
Daniel J KlionskyLife Sciences Institute and Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-7828-8118
Guido KroemerCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Institut Universitaire de France, Paris, France.ORCID 0000-0002-9334-4405
Jinbao LiuDAMP Lab, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Daolin TangDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-1903-6180
Rui KangDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-2725-1574
Southwestern Medical Center · USThird Affiliated Hospital of Guangzhou Medical University · CNInserm · FRUniversity of Michigan · US

Funding

The Pancreatic Cancer MicroenvironmentR01CA211070 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI KANG, RUI · 2017 to 2023
$1.4M
NCI NIH HHS R01 CA211070
6 · The paper itself

Abstract

Selective macroautophagy/autophagy maintains cellular homeostasis through the lysosomal degradation of specific cellular proteins or organelles. The pro-survival effect of selective autophagy has been well-characterized, but the mechanism by which it drives cell death is still poorly understood. Here, we use a quantitative proteomic approach to identify HPCAL1 (hippocalcin like 1) as a novel autophagy receptor for the selective degradation of CDH2 (cadherin 2) during ferroptosis. HPCAL1-dependent CDH2 depletion increases susceptibility to ferroptotic death by reducing membrane tension and favoring lipid peroxidation. Site-directed mutagenesis aided by bioinformatic analyses revealed that the autophagic degradation of CDH2 requires PRKCQ (protein kinase C theta)-mediated HPCAL1 phosphorylation on Thr149, as well as a non-classical LC3-interacting region motif located between amino acids 46-51. An unbiased drug screening campaign involving 4208 small molecule compounds led to the identification of a ferroptosis inhibitor that suppressed HPCAL1 expression. The genetic or pharmacological inhibition of HPCAL1 prevented ferroptosis-induced tumor suppression and pancreatitis in suitable mouse models. These findings provide a framework for understanding how selective autophagy promotes ferroptotic cell death.

Indexed as

AutophagyFerroptosisAnimalsCell DeathHippocalcinMiceProteomicsHippocalcinAutophagydegradationferroptosisinhibitormechanotransductionpancreasphosphorylation

Identifiers

PMID35403545
PMCPMC9809962
OpenAlexW4223447553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.